Vitamin D and Perimenopause: The Hormone That Most Women Are Deficient In

Vitamin D receptors are present throughout the brain, including in the hippocampus, prefrontal cortex, and substantia nigra. Vitamin D promotes the synthesis of neurotrophins (including NGF and BDNF), modulates dopamine and serotonin signaling, and reduces neuroinflammation through NF-κB suppression. Low vitamin D levels correlate with cognitive impairment, depression, and dementia risk in multiple large epidemiological studies. For perimenopausal women, who face declining estrogen-mediated BDNF support simultaneously, vitamin D deficiency represents a compounding neurological vulnerability. Observational studies consistently show that women with adequate vitamin D (>50ng/mL) experience less severe cognitive symptoms during the menopause transition.

Vitamin D's role in calcium absorption (it increases intestinal calcium uptake by 3–4 fold) makes it indispensable for perimenopausal bone protection. Without adequate vitamin D, supplemental calcium is poorly utilized. The optimal range for bone protection is 40–60ng/mL serum 25-OH-D — well above the 20ng/mL threshold used to define 'deficiency' in many lab ranges. Immunologically, vitamin D modulates both innate and adaptive immunity, reducing the autoimmune inflammatory tone that contributes to joint pain, thyroid dysfunction, and gut issues during perimenopause. The combination of vitamin D3 with vitamin K2 is essential: K2 directs calcium into bone (where vitamin D has absorbed it) rather than into arterial walls.

The first step is testing: request serum 25-OH-D and aim for 50–70ng/mL, not merely above the deficiency threshold. Most perimenopausal women in temperate climates require 2000–5000 IU vitamin D3 daily to reach and maintain optimal levels; exact dose depends on baseline, latitude, skin pigmentation, and body weight. Always pair with vitamin K2 (100–200mcg MK-7) and magnesium (which activates the enzymes that convert vitamin D to its active form). Take vitamin D3 with the largest fat-containing meal of the day for optimal absorption. Retest at 8–12 weeks to confirm target achievement. Toxicity is rare below 10,000 IU/day with adequate K2 — the historical fear of vitamin D toxicity was based on synthetic D2 doses without K2 cofactors.